siRNA, Anti-CCDC144A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT31231WQ-2OMe)

The product SIRGT31231WQ-2OMe is a type of small interfering RNA (siRNA) that targets CCDC144A gene and regulates the expression of gene. The siRNA interferes with the expression of CCDC144A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_014695.2
Related Diseases Smith-Magenis Syndrome
Purification HPLC
Target Gene
Gene ID 9720
Uniprot ID A2RUR9
Sub Cat Target Species Modification Scale  
SIRGT32231WQ-2F CCDC144A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT33231WQ-2MOE CCDC144A Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT34231WQ-LNA CCDC144A Human Locked Nucleic Acid (LNA) Inquiry
SIRGT31231WQ-RB CCDC144A Human Ribo-modified Inquiry
SIRGT32231WQ-BB CCDC144A Human Backbone-modified Inquiry

Related Products